Latest Capital Raises News

SPC Global Holdings confirms FY2025 pro forma EBITDA guidance of A$29 million, driven by strong early post-merger performance and strategic initiatives including site consolidation and leadership renewal.

Mighty Kingdom Limited has completed its entitlement offer, raising approximately A$475,000 through the issuance of 95 million new shares, yet a significant shortfall remains to be placed with investors.

Mirrabooka Investments Limited has launched a $85 million non-renounceable entitlement offer at $3.06 per share, inviting eligible shareholders to increase their holdings with a top-up facility. The offer aims to bolster the company’s investment capacity amid evolving market conditions.

Mirrabooka Investments Limited has announced a 1-for-7 entitlement offer priced at $3.06 per share, aiming to raise approximately $85 million to capitalize on emerging investment opportunities.

Imdex Limited reported a stabilisation in global exploration activity after a prolonged downturn, highlighting resilience despite a 19% revenue dip in 3Q25 and outlining a growth strategy focused on technology and integrated solutions.

Vinyl Group Ltd has raised $1.21 million through the exercise of options by key investors, eliminating all convertible notes and strengthening its balance sheet.

Epsilon Healthcare reports ongoing operational challenges post-voluntary administration while unveiling a new pharmacy subsidiary aimed at diversifying revenue streams and rebuilding market confidence.

A shareholder has lodged an application with the Takeovers Panel challenging FBR Limited’s upcoming extraordinary general meeting resolutions related to significant share placements and funding arrangements with Fidelity International.

Enlitic Inc. has been reinstated to trading on the ASX following its announcement of a new equity raise, signaling renewed investor interest in the health technology firm.

Enlitic has signed a binding MoU with GE HealthCare to deliver up to A$50 million in migration services over five years, contingent on a A$10 million equity raise that the company has now initiated.

Proteomics International Laboratories Ltd is raising up to $5.5 million through a $4 million placement and a $1 million Share Purchase Plan at $0.37 per share, offering shareholders a discounted entry and free attaching options.

FXG has announced a $17 million two-tranche placement priced at A$0.155 per share, aimed at advancing drilling and exploration activities in Alaska. The second tranche awaits shareholder approval, marking a pivotal funding milestone for the company.